Young Hee Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Young Hee Kim has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Byeol-A Yoon
Peripheral Neuropathy Research Center (PNRC), Dong-A University College of Medicine, Busan, 49201, Republic of Korea
1 shared publicationByung-Ok Choi
Department of Neurology, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea
1 shared publicationDa Kyeong Park
Biomedical Omics Group, Korea Basic Science Institute, Cheongju, Chungbuk, 28119, Republic of Korea
1 shared publicationHa Young Shin
Department of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03772, Republic of Korea
1 shared publication- Hwan Tae Park
Department of Translational Biomedical Sciences, Graduate School of Dong-A University, Busan, South Korea 49315; Department of Molecular Neuroscience, Peripheral Neuropathy Research Center, Dong-A University College of Medicine, Busan, South Korea 49315
1 shared publication Jong Hyun Kim
Laboratory of Stem Cell Differentiation, Department of Biological Science, Hyupsung University, Hwasung-si, 18330, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 2 July 2019
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 6 (7) , 1292-1301
p75 and neural cell adhesion molecule 1 can identify pathologic Schwann cells in peripheral neuropathies
Objective: Myelinated Schwann cells (SCs) in adult peripheral nerves dedifferentiate into immature cells in demyelinating neuropathies and Wallerian degeneration. This plastic SC change is actively involved in the myelin destruction and clearance as demyelinating SCs (DSCs). In inherited demyelinating neuropathy, pathologically differentiated and dysmyelinated SCs constitute the main nerve pathology.Methods: We investigated whether this SC plastic status in human neuropathic nerves could be determined by patient sera to develop disease‐relevant serum biomarkers. Based on proteomics analysis of the secreted exosomes from immature SCs, we traced p75 neurotrophin receptor (p75) and neural cell adhesion molecule 1 (NCAM) in the sera of patients with peripheral neuropathy.Results: Enzyme‐linked immunosorbent assay (ELISA) revealed that p75 and NCAM were subtype‐specifically expressed in the sera of patients with peripheral neuropathy. In conjunction with these ELISA data, pathological analyses of animal models and human specimens suggested that the presence of DSCs in inflammatory neuropathy and of supernumerary nonmyelinating or dysmyelinating SCs in inherited neuropathy could potentially be distinguished by comparing the expression profiles of p75 and NCAM.Interpretation: This study indicates that the identification of disease‐specific pathological SC stages might be a valuable tool for differential diagnosis of peripheral neuropathies.
- 2 July 2019
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 6 (7) , 1292-1301
Open Accessp75 and neural cell adhesion molecule 1 can identify pathologic Schwann cells in peripheral neuropathies
Objective: Myelinated Schwann cells (SCs) in adult peripheral nerves dedifferentiate into immature cells in demyelinating neuropathies and Wallerian degeneration. This plastic SC change is actively involved in the myelin destruction and clearance as demyelinating SCs (DSCs). In inherited demyelinating neuropathy, pathologically differentiated and dysmyelinated SCs constitute the main nerve pathology.Methods: We investigated whether this SC plastic status in human neuropathic nerves could be determined by patient sera to develop disease‐relevant serum biomarkers. Based on proteomics analysis of the secreted exosomes from immature SCs, we traced p75 neurotrophin receptor (p75) and neural cell adhesion molecule 1 (NCAM) in the sera of patients with peripheral neuropathy.Results: Enzyme‐linked immunosorbent assay (ELISA) revealed that p75 and NCAM were subtype‐specifically expressed in the sera of patients with peripheral neuropathy. In conjunction with these ELISA data, pathological analyses of animal models and human specimens suggested that the presence of DSCs in inflammatory neuropathy and of supernumerary nonmyelinating or dysmyelinating SCs in inherited neuropathy could potentially be distinguished by comparing the expression profiles of p75 and NCAM.Interpretation: This study indicates that the identification of disease‐specific pathological SC stages might be a valuable tool for differential diagnosis of peripheral neuropathies.
- 1 August 2005
- Published by Springer Nature in Biotechnology and Bioprocess Engineering
- Vol. 10 (4) , 322-328
Development of a sensitive bioassay method for quorum sensing inhibitor screening using a recombinantAgrobacterium tumefaciens
- 1 August 2005
- Published by Springer Nature in Biotechnology and Bioprocess Engineering
- Vol. 10 (4) , 322-328
Development of a sensitive bioassay method for quorum sensing inhibitor screening using a recombinantAgrobacterium tumefaciens